Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives by Bahamondes L et al.
 Newcastle University ePrints 
 
Bahamondes L, Mansour D, Fiala C, Kaunitz AM, Gemzell-Danielsson K.  
Practical advice for avoidance of pain associated with insertion of 
intrauterine contraceptives.  
Journal of Family Planning and Reproductive Health Care 2014, 40(1), 54-60 
 
Copyright: 
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non 
Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work 
non-commercially, and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ 
DOI link to article: 
http://dx.doi.org/10.1136/jfprhc-2013-100636 
Further information on publisher website: http://jfprhc.bmj.com/ 
Date deposited:  17th April 2014 
Version of article:  Published 
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License 
 ePrints – Newcastle University ePrints 
http://eprint.ncl.ac.uk 
 
Practical advice for avoidance
of pain associated with insertion
of intrauterine contraceptives
Luis Bahamondes,1 Diana Mansour,2 Christian Fiala,3
Andrew M Kaunitz,4 Kristina Gemzell-Danielsson5
1Professor of Gynaecology,
Department of Obstetrics and
Gynaecology, Faculty of Medical
Sciences, University of Campinas
(UNICAMP), Campinas, SP,
Brazil
2Consultant in Community
Gynaecology and Reproductive
Healthcare, Newcastle Hospitals,
Community Health, New Croft
Centre, Newcastle upon Tyne,
UK
3Director, Gynmed Clinic,
Vienna, Austria and Department
of Women’s and Children’s
Health, Karolinska Institutet,
Karolinska University Hospital,
Stockholm, Sweden
4Professor and Associate Chair,
Department of Obstetrics and
Gynecology, University of Florida
College of Medicine-Jacksonville,
Jacksonville, FL, USA
5Professor of Obstetrics and
Gynecology and Department
Chair, Department of Women’s
and Children’s Health,
Karolinska Institutet, Karolinska
University Hospital, Stockholm,
Sweden
Correspondence to
Dr Luis Bahamondes,
Department of Obstetrics and
Gynaecology, Faculty of Medical
Sciences, University of Campinas
(UNICAMP), Caixa Postal 6181,
Campinas, SP 13084-971,
Brazil; bahamond@caism.
unicamp.br
Received 11 April 2013
Revised 24 June 2013
Accepted 30 July 2013
Published Online First
27 September 2013
To cite: Bahamondes L,
Mansour D, Fiala C, et al.
J Fam Plann Reprod Health
Care 2014;40:54–60.
ABSTRACT
Few studies in the scientific literature provide clear
direction on the prevention or management of
pain associated with intrauterine contraceptive
(IUC) placement. Those that have been published
have studied small numbers of women and fail to
provide definitive conclusions. There are also no
guidelines available detailing recognised standard
approaches to this problem. The consensus
recommendations in this review focus primarily on
non-pharmacological and often non-evidence-
based interventions. This review includes general
considerations, practical recommendations for
both routine and more difficult cases and guidance
on the optimal choice of instruments. General
considerations, including pre-insertion counselling,
the setting for the procedure, the confidence and
technique of the provider and the interplay
between the provider and assistant, can influence
women’s level of anxiety and, in turn, influence
their perception of pain and their overall
experience. Further studies are required to refine
the optimal strategy for managing pain associated
with IUC insertion.
INTRODUCTION
Intrauterine contraceptives (IUCs) are
amongst the most effective of all contra-
ceptive methods1 2 and, according to
guidelines, are suitable for most women,
regardless of age or parity.3–8 Most IUC
insertions involve a brief procedure,
without complication, regardless of parity.9
Although there is evidence that nulliparous
women (nulligravidas and those who have
been pregnant but never given birth) may
experience more placement-related pain
than their parous counterparts,10–12 the
majority experience a level of pain that is
similar in intensity to that of menstru-
ation.13 However, a proportion of both
nulliparous and parous women experience
substantial pain: in a study of nulliparous
women, approximately 17% reported
severe pain associated with placement of a
levonorgestrel-releasing intrauterine system
(LNG IUS).14 In a study of mainly multip-
arous women (mean of two prior births;
n=46), approximately 11% reported
severe insertion-related pain.15 Such indivi-
duals need effective pain relief.
There are few studies in the scientific
literature that give clear guidance on the
management of pain associated with IUC
fitting. Those that have been published
have studied small numbers of women
and fail to provide definitive conclusions.
There are also no guidelines available
detailing recognised standard approaches
to this problem. In addition, data are
lacking on the clinical benefits of pain
management for IUC placements, and no
standard has been established.
Pharmacological strategies used by some
health care providers (HCPs) include treat-
ment given before the procedure (cervical
priming, oral analgesia and local anaesthe-
sia); during the procedure (local anaesthesia
administered reactively); and after the pro-
cedure [non-steroidal anti-inflammatory
drugs (NSAIDs) and opioid analgesia].
However, of the preventative interventions
that have been adequately evaluated, none
has shown clear evidence that pain is sig-
nificantly reduced during or after routine
IUC placement.16 In addition, most of the
regimens evaluated (e.g. those for cervical
priming, and pre-placement oral analgesia)
have been adopted from their use in other
gynaecological procedures such as hystero-
scopy or surgical abortion.17
Overall, the published evidence indi-
cates the need for effective pain relief for
some women undergoing IUC placement,
but offers limited guidance in this regard.
This review therefore presents consensus
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recommendations for improving women’s experiences
of IUC placement, with a specific focus on pain relief.
METHODOLOGY FOR DEVELOPING CONSENSUS
RECOMMENDATIONS
The authors were invited to a 1-day meeting to share
their practical experience when fitting IUCs. This was
supported by an educational grant from Bayer plc,
manufacturer of the LNG IUS (Mirena®) and a
copper-releasing intrauterine device (IUD, Nova T®).
The participants reviewed published evidence, shared
their personal experiences and produced consensus
recommendations for pain management in IUC
placement.
The present authors have recently published a
review of the evidence covering pain management
strategies for IUC insertion.18 The review presents
evidence-based recommendations and points out gaps
in the data and areas for further research. A total of
17 studies including 12 randomised controlled trials
(RCTs) provided no conclusive evidence that any
prophylactic pharmacological intervention reduces
pain associated with IUC insertion; however, one
review reported that NSAIDs may be effective in treat-
ing post-insertion pain.
In the absence of clear evidence supporting pharma-
cological interventions, the scope of the discussions was
expanded to include various non-pharmacological,
non-evidence-based strategies used in clinical practice.
The authors shared strategies from their own practice
and, through debate, areas of consensus were identified.
Attention to such factors may help to improve a
woman’s experience of IUC placement and these are
detailed in the following sections.
GENERAL RECOMMENDATIONS FOR IMPROVING
WOMEN’S EXPERIENCE
Pre-placement counselling
Women’s anxiety has been shown to contribute to
higher levels of perceived pain during IUC placement.
Women who believe that IUC placement will be a
painful procedure are more anxious and probably more
likely to take oral analgesics before the placement; conse-
quently, reduction of anxiety is a good strategy to reduce
pain during IUC placement.19 Non-pharmacological
interventions, such as pre-placement counselling, ‘verbal
anaesthesia’ and distraction during the procedure may,
therefore, be effective at reducing pain, although no
studies on these approaches have been published to date.
Counselling materials should be available that
provide the woman with realistic information about
what to expect during and after the procedure. The
level of pain that women experience is highly variable,
making it difficult to predict the level of discomfort
that an individual is likely to experience; this should
be explained in counselling. However, it can be useful
to explain the measures that will be taken to minimise
discomfort. The authors support the provision of a
sympathetic person to provide a ‘vocal local’ when
fitting IUCs.
The clinical setting
The placement of an IUC is a minor, office-based pro-
cedure and does not require the formal setting of an
operating room or special treatment room. A
bimanual examination must be performed prior to the
fitting of an IUC to help exclude pelvic pathology and
to determine the uterine position to reduce the risk of
uterine perforation. The authors suggest that ideally
the clinic room should be furnished with a gynaecol-
ogy couch with leg rests. If only a conventional flat
couch is available, the woman should be positioned so
that the HCP can fit the IUC from the end of the
couch. This will facilitate visualisation of the cervix,
cause less discomfort for the HCP and may improve
the ease of the insertion. However, the sensitivities
and expectations of the woman should always be
taken into account. The need for cervical dilatation or
pain relief is difficult to predict. We therefore recom-
mend that the necessary equipment for provision of
local anaesthesia and for cervical dilatation is kept
immediately to hand.
Vasovagal reactions can be difficult to predict;
accordingly, many HCPs keep the necessary drugs and
equipment to deal with these immediately accessible
during the procedure. These reactions are more likely
to occur in difficult or non-routine cases and during
procedures performed by less experienced HCPs, who
may have less technical expertise or confidence.
Recommendations for emergency drugs and equip-
ment vary between countries and providers should
follow their own local guidelines.
Confidence and technique of the HCP
IUC placements should ideally be performed by
experienced HCPs who have been appropriately
trained and who have maintained their skills. HCPs in
training must carry out placements under supervision
until both the trainee and trainer are satisfied that
clinical competence has been achieved. HCPs should
audit their practice and, if appropriate, consider refer-
ring complicated cases to a more experienced col-
league. The number of placements performed per
year is important with regard to outcome.20 21
Team interplay between the assistant and HCP
Women notice the team interplay between the assist-
ant and the HCP; a well-functioning team inspires
confidence and reduces women’s anxiety, which may,
in turn, have a positive impact on their perception of
pain.
Timing in the menstrual cycle
IUCs may be fitted at any point in the menstrual cycle
with insertion-related pain being similar throughout.
However, some HCPs prefer to fit IUCs within the
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first 7 days of the cycle as they feel that women
experience less pain (however, with no scientific evi-
dence) and because there is virtual certainty that the
woman could not be pregnant.
RECOMMENDATIONS FOR ROUTINE PLACEMENTS
The IUC package should not be opened until the uterus
has been successfully sounded
Difficulty with sounding can indicate a potentially dif-
ficult procedure. In this situation, the HCP should
ensure that local anaesthesia and fine cervical dilators
are available.
Clinicians should be aware of the origins of pain
During the insertion procedure, HCPs should be
aware of actions that could potentially cause pain and
should minimise these where possible. An accurate
initial bimanual examination will not only help to
prevent instrumental or IUC perforation, but may
help to reduce insertion pain. For example, if a
woman has a retroverted uterus, unnecessary pain will
be experienced if the sound is directed anteriorly.
Applying a tenaculum or Allis forceps, applying trac-
tion to the cervix, stretching or dilating the external
or internal cervical os (e.g. when inserting an Os
Finder, when passing the sound, dilators if needed, or
the IUC insertion tube), and touching the uterine
fundus during sounding or when ensuring that the
IUC is placed fundally, may all cause discomfort or
pain. Potential pain or problems should be anticipated
and each step should be explained to the woman to
help to minimise her anxiety and discomfort.
Clinicians should be open to women’s differing needs
for communication during the procedure
Women vary in the amount of information that they
wish to receive during the procedure. Therefore it is
important to ‘know your patient’ and to be aware that
women from different cultures respond differently to
the placement procedure. The presence of an assistant
during the procedure may help to reduce the woman’s
anxiety.
Routine use of ultrasound is not necessary but it may be
used in settings where it is readily available
The availability of ultrasound is not a prerequisite for
placing IUCs. However, when ultrasound is readily
available it can be used and it may be helpful in
certain situations. For example, after a difficult fitting
ultrasound may be useful for confirming that the
device has been positioned correctly in the uterine
cavity.
Routine cervical dilatation is not necessary
Routine dilatation of the cervix beyond the diameter
of the IUC inserter is not recommended because it
results in additional pain as well as increasing the risk
of a vasovagal episode. When the IUC inserter is first
applied to the cervical os, we recommend that the
clinician should pause for a few moments to allow the
os to slowly stretch and accommodate the inserter.
This makes the placement procedure easier and poten-
tially less painful. Few women, nulligravid or parous,
require cervical dilatation for IUC placement.
However this may be necessary in some cases even
when no particular difficulty has been encountered
with sounding.9 14
Clinicians should use non-pharmacological pain
management strategies
There is currently no effective evidence-based strategy
for managing pain in women who experience severe
discomfort during IUC placement. As mentioned pre-
viously, ‘verbal anaesthesia’ provided by an assistant is,
in our experience, one of the most effective ways of
reducing pain and anxiety. However, in routine prac-
tice the use of a small warm-water bottle inside a dis-
posable cover, held by the woman suprapubically, may
also be helpful. Concentration on holding the bottle
can distract her during the procedure and the warmth
can be comforting. Chemical warming packs may be a
suitable alternative.
RECOMMENDATIONS FOR MORE DIFFICULT
CASES
Our recommended approaches to various scenarios in
which IUC placement might be expected to be more
difficult are outlined below.
Scenario 1: Nulliparous and nulligravid women
IUC insertions for nulliparous and nulligravid women
should be considered to be routine cases. Most of
these women do not experience severe placement-
related pain. However, placement may be more
painful for some of these women when compared
with those who have experienced progressive labour.
For all IUC candidates, but particularly nulliparous
and nulligravid women, the clinician should be pre-
pared to administer a local anaesthetic if the woman
experiences moderate or severe pain, if she requests
pain relief, or if dilatation of the cervix is required.
Scenario 2: Uterine sounding is difficult and/or painful
It is difficult to predict whether a woman will have
complications or pain associated with IUC insertion.
If uterine sounding proves to be difficult and/or
painful, we recommend the administration of local
anaesthesia as an intracervical or paracervical block
before proceeding to cervical dilatation.
Scenario 3: Cervical stenosis
For cases in which attempted uterine sounding
demonstrates stenosis at either the external or internal
cervical os, we recommend consideration of adminis-
tration of local anaesthesia (see later) followed by
gentle use of an Os Finder (a malleable plastic tapered
Review
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dilator) or a suitable, preferably tapered, metal dilator.
If placement is not possible despite these measures,
the procedure should be discontinued.
If an IUC remains the woman’s contraceptive
method of choice, consideration may be given to cer-
vical priming with misoprostol, administered buccally
or vaginally 3 hours before a repeat procedure, or
sublingually 1 hour beforehand. However it should be
noted that several studies have suggested that while
misoprostol priming may permit easier passage of the
IUC (see Scenario 3), it is not effective in reducing
pain and it may, in fact, increase overall procedural
pain,15 22–24 often due to uterine cramping.
Although misoprostol has been studied extensively
for cervical priming to ease IUC placement, the data
are conflicting. One RCT15 showed no benefit when
misoprostol was compared to placebo given prior to
the removal and replacement of a LNG IUS. Another
RCT22 allocated the women to receive either 400 mg
misoprostol sublingually with 100 mg diclofenac, or
100 mg diclofenac alone. Use of misoprostol was asso-
ciated with significantly easier IUC insertion.
However, in a further RCT23 comparing misoprostol
with placebo, placement failure and placement-related
complications were similar in both groups. In all three
RCTs, reported placement pain was similar in those
receiving misoprostol, placebo15 23 or diclofenac
alone.22 In the opinion of the authors, if misoprostol
is to be used for cervical priming, a non-steroidal anal-
gesic (NSAID) should be offered in addition in order
to reduce its prostaglandin-mediated side effects
including uterine cramping.18
Scenario 4: A woman with extreme anxiety due to
anticipation of severe pain with IUC placement
A woman who anticipates that IUC placement will be
associated with severe pain may be extremely anxious
and may request that the procedure be performed
under general anaesthesia or sedation. Overall, the
risks of general anaesthesia are greater than those of
local anaesthesia. IUC placement performed under
general anaesthesia or sedation may also be associated
with a slightly increased risk of uterine perforation
due to the use of excessive force at the internal os,
although when performed by experienced clinicians,
with appropriate dilators or an Os Finder, the risk is
still very low. Use of general anaesthesia should, there-
fore, be limited to special situations, such as when a
woman with learning difficulties has opted for IUD
placement and it is considered that the procedure
would be impossible with no or local anaesthesia. As
an alternative to general anaesthesia, conscious sed-
ation following cervical priming could be considered
in a setting that should include adequate patient moni-
toring. In most cases, however, the woman’s anxiety
can usually be addressed with appropriate counselling
before the procedure and reassurance and/or distrac-
tion during the procedure. In a review of
approximately 1000 IUC placements performed over
1 year in Newcastle upon Tyne, UK, only one case was
referred for IUC placement under general anaesthesia
(D Mansour, personal communication). Furthermore,
in a Brazilian study evaluating LNG IUS placement in
nulligravid (n=159) and parous (n=477) women, no
anaesthesia was used and insertion failure was
observed in only 0.4% of women.9
CERVICAL ANAESTHESIA
Cervical anaesthesia can be administered paracervi-
cally or intracervically.25 Expert providers differ in
their preferences and, in the absence of a RCT com-
paring these methods for pain relief during IUC place-
ment, there is little evidence that either method is
more effective than the other.
Intracervical lidocaine gel
Two RCTs evaluated the use of intracervical 2% lido-
caine gel versus placebo prior to uterine sounding.
One trial used a cotton swab soaked in the study gel
or placebo and inserted into the cervical canal to the
level of the internal os for 60 seconds.26 No benefit
was found for lidocaine gel over placebo as used in
these two studies.26 27
Paracervical block
A paracervical block aims for regional anaesthesia of the
inferior hypogastric plexus and ganglia.28 Awide variety
of methods and techniques has been published.
Traditionally, a paracervical block was administered
using a 20 ml syringe, a 21 gauge needle and 15–20 ml
1% lidocaine, which was injected into the cervicovaginal
junction to a depth of 3–7 mm at two to six injection
sites. More recently, the technique for paracervical
blockade has been modified. Although there are no
studies to support this practice, many clinicians now use
a dental syringe with a finer (27 gauge) needle to admin-
ister a smaller volume of local anaesthetic, one or two
2.2 ml vials of 1% lidocaine, 2–3% mepivacaine or 4%
prilocaine, with or without a vasoconstrictor. A small
amount of local anaesthetic is injected into the anterior
cervical lip to reduce any discomfort caused by applying
the tenaculum. The remainder of the local anaesthetic is
then injected into the cervicovaginal junction, either lat-
erally or at the 4 and 8 o’clock positions.
Intracervical block
An intracervical block is an injection of local anaesthe-
sia into the cervical stroma, similar to the local anaes-
thetic block given when performing loop excision
procedures for treatment of cervical dysplasia.
Descriptions vary from injection into the anterior lip
of the cervix only, to circumferential injection at four
positions around the external os.25 The authors
suggest injecting the local anaesthetic through the cer-
vical canal, as close as possible to the internal os, at
the 4 and 8 o’clock positions. The advantage of
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intracervical block by either method is that when
using a dental syringe, only one or occasionally two
2.2 ml vials of local anaesthetic are needed, resulting
in a lower injection volume and, therefore, less pain
during the injection; there is no risk of intravascular
injection; and the onset of the anaesthetic effect is
immediate. Prilocaine with a non-adrenaline vasocon-
strictor, felypressin, is used to avoid adrenaline-related
adverse reactions (such as feeling faint or palpitations)
and to reduce bleeding following the injection.
THE MOST APPROPRIATE INSTRUMENTS
Regardless of whether a placement is considered routine
or difficult, using the most appropriate instruments may
optimise outcomes and improve women’s experience of
the procedure. In general, we recommend resterilisable
non-disposable instruments (Figure 1). The use of dis-
posable plastic and metal instruments (mainly specula) is
being adopted in many settings due to the increasingly
rigorous requirements for sterilisation. However, most
plastic tenacula fail to grasp the cervix effectively and
plastic scissors are not sharp enough or strong enough
to cut the IUC threads. Based on our collective experi-
ence in fitting IUCs, we recommend the following
instruments.
Speculum
Use of a short bivalve speculum usually facilitates
IUC placement. The advantage of a short speculum
is that more gentle traction can be placed on the
cervix, straightening the cervical canal and easing
placement by bringing the cervix closer to the
introitus.
Tenaculum
The authors advise that a tenaculum should always
be applied to stabilise the cervix and to reduce the
risk of uterine perforation by gently straightening
the cervico-uterine angle. Use of a fine tenaculum
(sometimes marketed for use in saline infusion son-
ography) or Judd-Allis forceps provides several
advantages: less pain associated with application
(one of the most painful aspects of the IUC place-
ment procedure), less trauma to and bleeding from
cervical tissue and greater ease in grasping a ‘flat
cervix’.
Syringe for administration of local anaesthesia
Administration of a local anaesthetic into the cervix
using a 10–20 ml disposable syringe is cumbersome.
The use of a dental syringe and needle greatly facili-
tates the administration of small volumes of more
effective local anaesthetic. The design of the dental
syringe gives the HCP more control of the syringe
and plunger; the syringe is narrow and the cervix can
therefore be viewed more easily when administering a
paracervical or intracervical block.
Figure 1 Recommended instruments for performing intrauterine contraceptive placements. (A) Mini and standard tenacula.
(B) Tapered versus parallel cervical dilators. (C) Dental syringe.
Review
58 Bahamondes L, et al. J Fam Plann Reprod Health Care 2014;40:54–60. doi:10.1136/jfprhc-2013-100636
 group.bmj.com on April 17, 2014 - Published by jfprhc.bmj.comDownloaded from 
Dilators
We recommend the use of tapered cervical dilators
increasing from 3 to 5 mm in diameter, in preference
to cylindrical (Hegar) dilators. These gently dilate the
cervical os and canal. However, if the only dilators
available are of the cylindrical type, we recommend
gentle sequential use of 3, 4 and 5 mm diameters.
Only in exceptional cases should it be necessary to
use a 6 mm diameter dilator. We generally recom-
mend the use of resterilisable instruments. However,
Os Finders and plastic tapered dilators are available;
these can be resterilisable or disposable and are a
good option. We do not recommend the use of
osmotic dilators (e.g. laminaria) for cervical priming
because of a lack of supporting studies.
CONCLUSIONS
No preventative pharmacological intervention has
been adequately evaluated in an RCT setting and been
shown to significantly reduce pain associated with
IUC placement. General considerations, including pre-
placement counselling, the setting in which the actual
procedure is performed, the confidence and technique
of the clinician and the interplay between the HCP
and assistant, can positively or negatively impact on a
woman’s level of anxiety and therefore potentially
influence her perception of pain as well as her overall
experience. Ongoing efforts are required to refine the
optimal strategy for managing pain associated with
IUC placement and to improve women’s experience
of the procedure. In addition, there will be benefits if
best practices are shared internationally.
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